Acquired & transformed the only GF injectable plant in Jordan to achieve $ 60 million sales in Year 5.
Managed the S&M team in Jordan that tripled the sales in 5 years
Successful market access projects in Iraqi & Algeria
Established Contract R&D and Quality Laboratory, Partnership with Labatec Switzerland
Injected Two Biosimilars (Adalimumab & Herceptin) from EU Approved source to the Saudi, GCC & MENA markets
Established an Opthalmic Line in UAE (Full Technical & Business Services)
Complete Oral Dosage Form Site Preparation & Installation in Iraq
Registered our private label food supplement products